SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-047509
Filing Date
2023-08-28
Accepted
2023-08-28 16:16:33
Documents
1
Period of Report
2023-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8667
  Complete submission text file 0001209191-23-047509.txt   11716
Mailing Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104 650-233-2211
Versant Side Fund III, L.P. (Reporting) CIK: 0001456585 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 231215720

Mailing Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104 650-233-2211
Versant Venture Capital III, L.P. (Reporting) CIK: 0001456586 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 231215721

Mailing Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104 650-233-2211
Versant Ventures III, LLC (Reporting) CIK: 0001456587 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 231215722

Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations